help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on April 17, 2007
Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2006-2280
A more recent version of this article appeared on July 1, 2007
This Article
Right arrow Author Manuscript (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
92/7/2720    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Meex, S. J. R.
Right arrow Articles by de Bruin, T. W. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Meex, S. J. R.
Right arrow Articles by de Bruin, T. W. A.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Metabolism

Submitted on October 18, 2006
Accepted on April 11, 2007

ATF6 polymorphisms and haplotypes are associated with impaired glucose homeostasis and type 2 diabetes in Dutch Caucasians

Steven J. R. Meex*, Marleen M. J. van Greevenbroek, Torik A. Ayoubi, Robert Vlietinck, Jana V. van Vliet-Ostaptchouk, Martin H. Hofker, Vicky M. M-J. Vermeulen, Casper G. Schalkwijk, Edith J. M. Feskens, Jolanda M. A. Boer, Coen D. A. Stehouwer, Carla J. H. van der Kallen, and Tjerk W. A. de Bruin

Cardiovascular Research Institute Maastricht (CARIM). Department of Internal Medicine, Laboratory of Molecular Metabolism and Endocrinology, University of Maastricht, the Netherlands; Cardiovascular Research Institute Maastricht (CARIM). Department of Population Genetics, Genomics and Bio-informatics, University of Maastricht, the Netherlands; Department of Human Genetics, University of Leuven, Belgium; Cardiovascular Research Institute Maastricht (CARIM). Department of Molecular Genetics, University of Maastricht, the Netherlands; Department of Pathology and Laboratory Medicine, University Medical Center Groningen and University of Groningen, the Netherlands; Division of Human Nutrition, Section Nutrion and Epidemiology, Wageningen University, the Netherlands; Centre for Nutrition and Health, National Institute for Public Health and the Environment, Bilthoven, The Netherlands; GlaxoSmithKline, Translational Medicine & Genetics 5.5622, North Carolina 27709, USA

* To whom correspondence should be addressed. E-mail: steven.meex{at}intmed.unimaas.nl.

Context: Activating Transcription Factor 6 (ATF6) is critical for initiation and full activation of the unfolded protein response. An association between genetic variation in ATF6 and type 2 diabetes was recently reported in Pima Indians.

Objective: To investigate the broader significance of this association for type 2 diabetes, replication studies in distinct ethic populations are required. We investigated ATF6 for its association with type 2 diabetes in Dutch Caucasians.

Design: Genetic association study

Setting: Academic research laboratory

Study participants: Two independent Dutch cohorts. Cohort 1 (N=154) was used to evaluate genetic variation in the ATF6-gene in relation to glucose homeostasis in the general population. Cohort 2 (N=798) consisted of patients with type 2 diabetes, impaired glucose tolerance, impaired fasting glucose, and normoglycaemic control subjects and was used to investigate ATF6 polymorphisms for their contribution to disturbed glucose homeostasis and type 2 diabetes.

Main outcome measures: Sixteen tag-SNPs were genotyped in all subjects of both cohorts. Those SNPs included three nonsynonymous coding variants and captured all common allelic variation of ATF6.

Results: Our data show that common ATF6 variants are associated with elevated glucose levels in the general population (Cohort 1, P=0.005-0.05). Furthermore, the majority of these variants, and haplotypes thereof, were significantly associated with impaired fasting glucose, impaired glucose tolerance and type 2 diabetes. (Cohort 2, p=0.006-0.05). Associated variants differ from those identified in Pima Indians.

Conclusions: Our results strengthen the evidence that one or more variants in ATF6 are associated with disturbed glucose homeostasis and type 2 diabetes.


Key words: unfolded protein response • endoplasmic reticulum stress • genetic association study • single nucleotide polymorphisms • type 2 diabetes




This article has been cited by other articles:


Home page
Endocr. Rev.Home page
D. Scheuner and R. J. Kaufman
The Unfolded Protein Response: A Pathway That Links Insulin Demand with {beta}-Cell Failure and Diabetes
Endocr. Rev., May 1, 2008; 29(3): 317 - 333.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society